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America, the incidence of SLE was reported 
around 2 to 8 cases per 100.000 people per year. In 
USA, prevalence of SLE was reported in 51 cases 
per 100.000 people. In 2010, there were 291 SLE 
patients registered at Rheumatology Outpatient 
Department dr. Hasan Sadikin General Hospital 
Bandung. It was accounted for about 10,5% of all 
patients registered at Rheumatology Outpatient 
Clinic. The increase of SLE incidence in the last 
40 years is implicated due to the invention of SLE 
diagnostic tools.1 Prevalence of SLE is six to ten 
fold higher in female than male. The prevalence 
was 128,7 cases per 100.000 people and incidence 
was 9,3 cases per 100.000 people. SLE prevalence 
was 2,3 fold higher in black people.2
Clinical manifestation of SLE involves joints, 
skin, kidney, lung, heart, central nervous system, 
and immune system. The wide clinical spectrum 
of SLE causes the difficulties in establishing the 
diagnosis. Further, patient’s chief complaints are 
seldom specific. If the SLE patients get delayed 
therapy, disease activity may harm the patients.3
According to 10 years - research study 
conducted on 1.000 SLE patients in seven countries 
in Europe, the proper of most common SLE 
manifestation were athritis (48,1%), malar rash 
(31,1%), nephropathy (27,9%), and photosensitivity 
(22,9%).4 About 5 to 10 percent of SLE patient 
showed muscle enzymes elevation, include 
creatinine kinase, aminotransferase, aldolase, 
and lactate dehydrogenase.5 This explained that 
musculoskeletal manifestation in SLE patients had 
high occurrance. 
The most prevalent musculoskeletal 
manifestation of SLE was arthritis, that marked 
by joint pain, effusion, and swollen joint of hand, 
wrist, and knee.5 Arthritis can significantly decrease 
patient’s life quality. It make some disablities in daily 
activity, includes walking, climbing stairs, kneeling, 
and gripping fingers. The conditions may affect the 
psychosocial life of SLE patients.6,7 According to 
the research done at El Menia University Hospital, 
Egypt, avascular bone necrosis was occured in 
15% of SLE patients.8 Several studies performed 
in Brazil reported,  beside arthritis, 2.8% of SLE 
Abstract
Background: Systemic Lupus Erythematosus 
(SLE) is an autoimmune disease with wide range of 
clinical symptoms. The patients frequently complain 
musculoskeletal involvement during the active state 
of the disease. Musculoskeletal manifestation in SLE 
patients is an important sign in making early diagnosis 
and monitoring treatment response. This study aims 
to determine the presentation of musculoskeletal 
involvement of SLE patients in Dr. Hasan Sadikin General 
Hospital Bandung.
Methods: a descriptive cross-sectional quantitative 
study done by interviewing SLE patients concerning 
musculoskeletal manifestation as the primary data and 
tracking their medical record as the secondary data. 
Study was conducted between September to November 
2016 in Rheumatology Clinic Dr. Hasan Sadikin General 
Hospital Bandung.     
Result: Ninety-seven SLE patients, 91 females (93,81%) 
and 6 males (6,19%), were enrolled in this study with 
mean age 35.12 (±10.91) years. The three highest 
proportions of muskuloskeltal manifestations were 
arthritis of the knee (84,5%), myalgia of upper back 
(40,2%), and muscle weakness (15,5%). We did not 
find any Jaccoud’s Arthropathy (JA) and tendinitis 
manifestation. Osteoporosis were occured in 4 
patients (4,12%), whereas gout arthritis, spondytlitis, 
osteoarthritis, rotator cuff syndrome, and rhupus were 
only occured in one patient (1,03%), respectively.  
Conclusion: The common musculoskeletal 
manifestation in SLE patients were arthritis of knee, 
myalgia of upper back, and muscle weakness.  Only 
small portion of patients suffered from osteoporosis, 
gout arthritis, spondytlitis, osteoarthritis, rotator cuff 
syndrome, and rhupus. 
Keyword: musculoskeletal manifestation, 
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Background
Systemic Lupus Erythematosus (SLE) is an 
autoimmune disease that has wide clinical 
spectrum and organs involvement. The prevalence 
and incidence of SLE have been increasing in 
recent year. In Europe, North America, and South 
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patients had Jaccoud’s Arthropathy (JA) which marked by 
fingers and toes deformities,9 and about 95 percent of SLE 
patients complained general myalgia.10
Despite the high involvement of musculoskeletal, the 
data of musculoskeletal manifestations in SLE patients in 
Indonesia has not been documented. This study was designed 
to identify the musculoskeletal involvements of SLE patients 
at Dr. Hasan Sadikin General Hospital Bandung, Indonesia. 
Methods 
We used a descriptive cross-sectional study method. The 
primary data were obtained through interview with SLE 
patients about symptoms of the musculoskeletal system and 
the secondary data were obtained from medical records of 
patients. The study was conducted in Rheumatology Clinic Dr. 
Hasan Sadikin General Hospital Bandung from September-
November 2016. The minimum sample required in our 
study were 97 patients based on the formula for categorical 
and descriptive sample measurements that were taken 
consecutively. Samples included in the study were patients 
who have been diagnosed with SLE using ACR revised 
criteria, aged ≥14 years, and registered as an outpatient. 
Patients whose medical records with incomplete identity 
and clinical condition reports were excluded in this study. 
Ethical clearance for this study has been received from the 
Commission on Health Research Ethics Faculty of Medicine, 
University of Padjadjaran with number 540 / UN6.C1.3.2 / 
KEPK / PN / 2016 and licence for this study has been received 
from Direktorat Jenderal Pelayanan Kesehatan Dr. Hasan 
Sadikin General Hospital.  
All subjects got the explanation about the study and signed 
a consent form. Patient’s demographic data (name, age, date of 
birth, occupation, address, and telephone number), duration of 
lupus, and the location of first diagnosis of SLE were obtained 
through interview. The interview results were recorded on 
a case report form (CRF). History of hypertension, trauma, 
infection, anemia, BMI, dyslipidemia, and definitive diagnosis 
of the musculoskeletal system were obtained through medical 
records of patients.
Data were collected and analyzed using Microsoft Excel 
2013. Standard deviation for numerical data and percentages 
for categorical data were calculated
Result
There were 100 SLE patients met the inclusion criteria. One 
patient was excluded due to disagreement to join the study, 
two patients were excluded due to incomplete interview. 
Ninety-seven patients included as subjects in this study. 
Mean age of subjects was 35,12 years (SD 10,103). There 
were 91 (93,81%) females. The most prevalent group age was 
between 30-39 years old (34,02%). Among all samples, 63 
patients (64,95%) were housewife. Most patients (46,39%) 
had been diagnosed as SLE for more than 5 years. There were 
70 patients (72,16%)  lived in Bandung. Demographic data of 
SLE patients were presented in Table 1.  
 Table 1. Demographic Data of SLE Patients 
Characteristic Data (N=97)
Mean Age (years)
Group age (N,%)
≤15 years
16 – 19 years
20 – 29 years
30 – 39 years
40 – 49 years
50 – 59 years
60 – 69 years
Gender (N,%)
Male
Female
BMI (N,%)
Underweight
Normal
Overweight
Obese
Occupation (N,%)
Housewife
Employee
Enterpreneur
Student
Teacher
Health Worker
Housemaid
Unemployment
SLE duration  (N,%) 
<1 year
1 – 3 years
3 – 5 years
>5 years
Not Identified
Residency (N,%) 
Bandung
Non-Bandung
35.12 ± 10.103
1 (1.03%)
2 (2.06%)
29 (29.89%)
33 (34.02%)
24 (24.74%)
7 (7.21%)
1 (1.03%)
6 ( 6.19% )
91 (93.81% )
9 (9.27%)
73 (75.25%)
11 (11.34%)
4 (4.12%)
63 (64.95%)
15 (15.46%)
7 (7.22%)
5 (5.15%)
4 (4.12%)
1 (1.03%)
1 (1.03%)
1 (1.03% )
17 (17.52%)
16 (16.49%)
17 (17.52%)
45 (46.39%)
2 (2.06%)
70 (72.16%)
27 (27.83%)
According to the medical history which is presented in Table 2, 
12 patients (12.37%) have hypertension, 73 patients (75.25%) 
had normal BMI, and four patients were obese. The most 
frequent of infectious disease from 2015 to 2016 was acute 
respiratory syndrome accounted for 11 patients (11.34%). 
Table 2. Medical History of SLE patients (N=97) 
Medical History Results
Hypertension (N,%)
Obesity
Trauma
Infectious Disease periode 2015 – 2016 (N,%)
Acute Respiratory Syndrome
Periodontitis
Asymptomatic Bacteriuria
Pulpitis
Dental Caries
Tuberculosis
Tinea Corporis 
Gingivitis
Urinary Tract Infection
Herpes Zooster
12 (12.37%)
4 (4.12%)
1 (1.03%)
11 (11.34%)
8 (8.24%)
8 (8.24%)
5 (5.15%)
5 (5.15%)
4 (4.12%)
4 (4.12%)
4 (4.12%)
3 (3.09%)
3 (3.09%)
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Medical History Results
Gastroenteritis 
Bronchitis 
Pneumonia
Typhoid Fever
Candidiasis
Impetigo
Hypercholesterolemia
Anemia
3 (3.09%)
3 (3.09%)
2 (2.06%)
1 (1.03%)
1 (1.03%)
1 (1.03%)
6 (6.18%)
23 (23.71%)
Among all samples, 96 patients had musculoskeletal 
involvement during disease activity and the manifestation 
were varied. There were 82 patients (84.5%)  had knee 
arthritis, 64 patients (66%) had right fingers arthritis, and 61 
patients (62,9%)  had left fingers arthritis. Presentation of 
arthritis in SLE patients are showed in Figure 1. 
Figure 1. Arthritis in SLE patients (N=97)
There were 39 (40,2%) patients had myalgia in upper 
back, 37 (38,1%) patients had myalgia in neck, and 31 (32%) 
patients had myalgia in lower back. Myalgia manifestation of 
SLE patients are presented in Figure 2.
In this study, Jaccoud’s Arthropathy and tendinitis were 
not found. Other musculoskeletal manifestation are presented 
in Figure 3. 
Figure 2. Myalgia in SLE Patients
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Discussion
In this study, demographic data showed that female’s 
prevalence was higher than male’s, this is consistent with study 
done by Julia F. Simard et al., stated the prevalence of SLE in 
Sweden on 2010, were 144 in females per 100.000 SLE cases 
a year and only 25 in males per 100.000 SLE cases;11 Also 
accordance with the epidemiology study of SLE patients in 
America which is six fold higher in females than males.12 It is 
suggested due to higher leptin level found in females than in 
males. Leptin is known could induce autoantibody and inhibit 
immune regulation.13,14
SLE was more frequently found in patients ranged from 
30 to 39 years old. This condition is caused by the higher 
level of esterogen in reproductive age. Estrogen could cause 
disregulation of immune system. Therefore, SLE is nine fold 
more frequent in reproductive-aged females than in males 
with the same age.15 
Infection in SLE was likely caused by the immunosuppressant 
drugs used for controlling disease activity. Infections may 
induce the flare in SLE. This is caused by molecular mimicry 
of immune system stimulates autoimmunity by cross-reactive 
process of immune system and self-antigen. Infection of 
Herpes virus, Retrovirus, and RNA virus could induce this 
reaction. Furthermore, infection caused by Candida albicans, 
Staphylococcus aureus, Salmonella, and Escherichia coli are 
more frequent in SLE and cause flare.16 In this study, etiology 
of infectious diseases are not listed in medical record so the 
comparison of infectious agents could not be presented. 
In our study, we found 82 patients (84,5%) had knee 
arthritis, 64 patients (66%) had arthritis of right fingers, and 
61 patients (62,9%) had arthritis of left fingers. Arthritis may 
occur in almost all joints of SLE patients. This finding is 
similar with Smith PP, et al. study17, which stated that in SLE, 
arthritis could manifest in all joints with knee involvement 
was the highest proportion. This is nearly similar to article 
written by Manole Cajacaru et al., that stated arthritis in 
SLE frequently affect toes, wrist, and knee.18 High level of 
cytokine is correlated with SLE disease activity level and 
arthritis manifestation. Cytokine induction resulted from 
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the deposition of antigen-antibody complex may activate 
complement system in high filtration area, such as joints and 
kidneys. 5,19 
Myalgia of upper back occured in 40.2% SLE patients, 
myalgia of neck occured in 38.1% patients, and myalgia of 
lower back occured in 32% patients. This result concordants 
with study conducted by A Zoma, which found myalgia in 
40-80% of SLE patients during flare state.20  Muscle ache 
in SLE is related to the activation of complement system 
by antigen-antibody complex deposition which is similar 
to patophysiology of arthritis. This complement activation 
ultimately induces inflammation in muscle tissue.5
Jesscia L, et al. reported myositis were found in 55 SLE 
patients aged 9 – 21 years old in Southeast America, 31% 
of 55 myositis patients  had proximal muscle weakness and 
muscle enzyme elevation, such as creatinine kinase, AST, 
aldolase, and LDH.21 The report is dissimilar with our study 
result. We only found 15,5% of SLE patients complained 
muscle weakness. The differences were possibly occured due 
to the fewer of total sample used in previous study than in 
our study and the difference of sampling technique used. In 
the other hand, Joseph Font, et al., study found lower rate of 
muscle weakness in SLE patients, which were found only in 
7% of 600 SLE patients.22 These distinct results are probably 
due to total samples used in Joseph F,et al study is higher than 
in our study despite the same level of disease activity. 
There were not any Jaccoud’s Arthropathy (JA) cases 
found in this study. This is inconsistent with previous study 
done by Thelma L Skare et al., who  found 6,17% JA in 
SLE patients.23 The dissimilarity is probably caused by the 
difference characteristic of study sample and the amount of 
samples used between the studies.  However, we had same 
level disease activity among the samples joined in the research. 
Tendinitis, as a cause of JA, was also not found in our study. 
This is contradicted with previous study by T.Ogura et al., 
who concluded that tendinitis was more frequent in SLE than 
Rheumatoid Arthritis.24 This difference may occur due to the 
lack of data in medical record and no subjective data regarding 
tendinitis was obtained. 
Osteoporosis were found in 4 (4,12%) SLE patients. The 
result is consistent with review-article conducted by García-
Carrasco M, et a.l that found osteoporosis in 4.0-48.8% SLE 
patients.25 Osteoporosis in SLE is related to low osteocalcin 
level, the habits to avoid UV light may influence vitamin-D 
level. Furthermore, the adverse effect of corticosteroid used 
for long period may also play roles.25 Our study found only 
one SLE patient with spondilitis. This conclusion is similar 
to literature review written by Figen T, et al. that conclude 
spondilitis as a rare condition among SLE patients. 26
Study done by Tani C. et al27 found 10 (9,7%) of 103 SLE 
patients with RA, or Rhupus, at Rheumatology Unit of Pisa 
University Italy. This percentage was slightly higher than 
our study (1,03%). Despite the same sampling technique, the 
length of period and amount of sample used in Tani C, et al 
was wider than our study.
The limitation of the study is the comparison among 
variables could not be done due to lack of article discusses the 
same topic, especially in Indonesia. Researcher interpretation 
to musculoskeletal symptoms could cause bias. 
Conclusions
The most common musculoskeletal manifestations in SLE 
patients were knee arthritis and myalgia of the upper back 
muscles. Patients with symptoms of muscle weakness were 
low compared to other studies. JA manifestation and tendinitis 
were not found in this study. Osteoporosis was the most 
common other musculoskeletal manifestation compared to 
spondylitis, rhupus, osteoarthritis, rotator cuff syndrome, and 
gout.
Further studies should be conducted on a multi-
characteristic of populations in Indonesia with a cohort study 
design so that the clinical pictures of patients with SLE are 
more accurate. Longer period of the study is needed to include 
more subjects. 
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